DD03

D&D Pharmatech

Drug Candidate

DD03

Summary

Peptide based, oral GLP-1R/GCGR dual agonist for Obesity & NASH

Mechanism of Action

Oral GLP-1R/ GCGR Dual Agonist

Indication

Obesity & NASH

Development Stage

Drug Discovery